Integra LifeSciences Holdings Corporation: BMO cuts target price to $15 from $18
IART•BMO cut its target price for Integra LifeSciences Holdings Corporation to $15 from $18.
Related News
Eli Lilly presents new EBGLYSS data from Phase 3 ADorable-1 pediatric atopic dermatitis study at Fall Clinical 2026
LLY•
Fortive Corporation: Truist Securities cuts target price to $63 from $68
FTV•
CareTrust REIT: BMO cuts target price to $45 from $47
CTRE•
AECOM: Truist Securities cuts target price to $75 from $85
ACM•
Distribution Solutions Group set for $35-a-share buyout by LKCM Headwater affiliates
DSGR•